@FierceBiotech: Roche's hostile Illumina bid highlights two hot trends in biopharma. News | Follow @FierceBiotech
@JohnCFierce: New research links children's exposure to PFCs--found all over the place--with lowered immune response to vaccines. Article | Follow @JohnCFierce
@MarkHFierce: Adult stem cells helped build a better rat penis. You read that right. More | Follow @MarkHFierce
> The FDA has approved a new gel from Leo Pharma which treats a skin condition linked to the later development of cancer. Article
> Woburn, MA-based Aphios has won a $2.4 million grant from the NIH to finance its work on a new treatment for Alzheimer's. Story
> Galena has started a late-stage study of NeuVax, its breast cancer vaccine hopeful that targets HER2 1+ and 2+ patients. Story
> Spain's Almirall is forming a drug discovery alliance with Galapagos focused on one of Almirall's respiratory targets. Release
Pharma News
> Novartis expects lower 2012 margin, despite cost cuts. More
> Reps get $99M settlement in Novartis OT case. News
Drug Delivery News
> Report: Roche transferring Israeli diabetes operations to Europe. Story
> Next-gen nanoparticles deliver cancer drugs at just the right moment. Article
> Mylan concocts ready-to-use epilepsy drug variation. News
> University of Arkansas heightens nanomedicine research efforts. Item
Medical Device News
> Medtronic concludes enrollment in 'extreme risk' study of CoreValve. Item
> Roche looks to snatch up Illumina for $5.7B. More
> Mevion scores $45M for proton therapy system. News
> CN Creative nails $3.1M for electronic inhaler smoking cessation device. Article
Biomarkers News
> Blood test could predict kidney disease 10 years early. Story
> Quintiles helps form personalized medicine joint venture. News
> Researchers fingerprint head, neck cancer for better diagnostics. Article
> Crosswords, reading cut Alzheimer's biomarker. More
And Finally... Researchers in Spain have developed a new approach to diagnosing Alzheimer's that may only require a simple blood test. Release